| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| SRN-001 | SRN-001 | Phase 1 Clinical | siRNAgen Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis; Chronic Kidney Disease-Mineral and Bone Disorder | Details |
| PMG-1015 | PMG-1015 | Phase 1 Clinical | Pulmongene Ltd | Idiopathic Pulmonary Fibrosis | Details |